Association Between Serum ANGPTL8 Levels and PCOS and Its Clinical Utility in Diagnosis
Journal of Obstetrics and Gynaecology Research · 2026-08 · 52 (8)
DOI: 10.1111/jog.70455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 14.08.2026. Verfasst von Yanli Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Angiopoietin-like Proteins, Peptide Hormones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Science Research Project of Hebei Province.
Abstract (Originalsprache)
Objective
To analyze the correlation between angiopoietin‐like protein 8 (ANGPTL8) and polycystic ovary syndrome (PCOS) and explore the clinical diagnostic value of ANGPTL8 in PCOS.
Methods
In this retrospective case–control study, we included 94 PCOS patients (study group) from our hospital's Reproductive Center from June 2023 to December 2024 and 116 age‐matched women with normal ovarian function (control group) from the Gynecology Department. Serum levels of anti‐Müllerian hormone (AMH), sex hormones, and ANGPTL8 were measured in all participants.
Results
The study group exhibited higher AMH, LH, LH/FSH ratio, and E2 levels compared to the control group ( p < 0.001). Serum ANGPTL8 levels were lower in PCOS patients ( p < 0.001). Logistic multivariate regression analysis identified BMI, AMH, LH, and ANGPTL8 as independent influencing factors for PCOS. Elevated ANGPTL8 levels were associated with reduced PCOS risk ( p < 0.001), while increased BMI, AMH, and LH levels correlated with higher PCOS risk ( p < 0.05). At a cutoff value of 12.871 ng/mL, ANGPTL8 demonstrated a sensitivity of 90.4%, specificity of 77.6%, and an area under the curve (AUC) of 0.881 (95% CI: 0.836–0.926, p < 0.001), indicating moderate‐to‐high diagnostic efficacy. The combined use of ANGPTL8 with AMH or sex hormones improved diagnostic performance compared to individual markers. Notably, the combination of ANGPTL8 and sex hormones yielded a higher AUC (0.980) than ANGPTL8 with AMH (AUC = 0.928).
Conclusion
Serum ANGPTL8 levels are significantly lower in PCOS patients and inversely associated with PCOS risk. ANGPTL8 shows promise as a novel diagnostic biomarker for PCOS, especially when integrated into multi‐marker panels with existing hormonal parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mental Health, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Ultrasound, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Reproductive Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
ORCID-Profile: Yuxiao Zhang
Förderung
- Medical Science Research Project of Hebei Province
Zitieren
APA
Wang, Y., Du, C., Guo, X., Ma, X., Feng, Y., Deng, Y., & Zhang, Y. (2026). Association Between Serum ANGPTL8 Levels and PCOS and Its Clinical Utility in Diagnosis. Journal of Obstetrics and Gynaecology Research, 52(8). https://doi.org/10.1111/jog.70455
Vancouver
Wang Y, Du C, Guo X, Ma X, Feng Y, Deng Y, et al. Association Between Serum ANGPTL8 Levels and PCOS and Its Clinical Utility in Diagnosis. Journal of Obstetrics and Gynaecology Research. 2026;52(8). doi:10.1111/jog.70455
BibTeX
@article{Wang2026,
author = {Wang, Yanli and Du, Chongbo and Guo, Xuejia and Ma, Xiaowen and Feng, Yanping and Deng, Yandong and Zhang, Yuxiao},
title = {Association Between Serum ANGPTL8 Levels and PCOS and Its Clinical Utility in Diagnosis},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {8},
doi = {10.1111/jog.70455}
}
EUVIMED